CliffBio
small molecule

ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE

ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
Active ingredientABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
StrengthEQ 300MG BASE;150MG;300MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2013
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.